CN106616999A - 一种多糖红曲复方抗肿瘤癌固体饮料及其制备方法 - Google Patents
一种多糖红曲复方抗肿瘤癌固体饮料及其制备方法 Download PDFInfo
- Publication number
- CN106616999A CN106616999A CN201611260368.7A CN201611260368A CN106616999A CN 106616999 A CN106616999 A CN 106616999A CN 201611260368 A CN201611260368 A CN 201611260368A CN 106616999 A CN106616999 A CN 106616999A
- Authority
- CN
- China
- Prior art keywords
- polysaccharide
- monas cuspurpureus
- cuspurpureus went
- powder
- solid beverage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000005017 polysaccharide Substances 0.000 title claims abstract description 167
- 229920001282 polysaccharide Polymers 0.000 title claims abstract description 167
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 62
- 201000011510 cancer Diseases 0.000 title claims abstract description 59
- 230000000259 anti-tumor effect Effects 0.000 title claims abstract description 53
- 239000007787 solid Substances 0.000 title claims abstract description 50
- 235000013361 beverage Nutrition 0.000 title claims abstract description 47
- 241000228347 Monascus <ascomycete fungus> Species 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title claims description 19
- -1 polysaccharide compound Chemical class 0.000 title abstract 5
- 244000113306 Monascus purpureus Species 0.000 claims abstract description 233
- 235000002322 Monascus purpureus Nutrition 0.000 claims abstract description 233
- 150000004676 glycans Chemical class 0.000 claims abstract description 162
- 239000000843 powder Substances 0.000 claims abstract description 149
- 230000004151 fermentation Effects 0.000 claims abstract description 61
- 235000020710 ginseng extract Nutrition 0.000 claims abstract description 49
- 239000000284 extract Substances 0.000 claims abstract description 47
- 230000000694 effects Effects 0.000 claims abstract description 41
- 239000002994 raw material Substances 0.000 claims abstract description 39
- 238000010563 solid-state fermentation Methods 0.000 claims abstract description 25
- 238000009629 microbiological culture Methods 0.000 claims abstract description 4
- 229940057059 monascus purpureus Drugs 0.000 claims description 175
- 241000209094 Oryza Species 0.000 claims description 83
- 235000007164 Oryza sativa Nutrition 0.000 claims description 83
- 235000009566 rice Nutrition 0.000 claims description 83
- 229940089161 ginsenoside Drugs 0.000 claims description 65
- 229930182494 ginsenoside Natural products 0.000 claims description 65
- 241000233866 Fungi Species 0.000 claims description 58
- 238000000855 fermentation Methods 0.000 claims description 52
- 150000001875 compounds Chemical class 0.000 claims description 44
- 150000003384 small molecules Chemical class 0.000 claims description 34
- 238000000034 method Methods 0.000 claims description 32
- PCZOHLXUXFIOCF-UHFFFAOYSA-N Monacolin X Natural products C12C(OC(=O)C(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 PCZOHLXUXFIOCF-UHFFFAOYSA-N 0.000 claims description 30
- PCZOHLXUXFIOCF-BXMDZJJMSA-N lovastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 PCZOHLXUXFIOCF-BXMDZJJMSA-N 0.000 claims description 30
- 229960004844 lovastatin Drugs 0.000 claims description 30
- QLJODMDSTUBWDW-UHFFFAOYSA-N lovastatin hydroxy acid Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(C)C=C21 QLJODMDSTUBWDW-UHFFFAOYSA-N 0.000 claims description 30
- 231100000678 Mycotoxin Toxicity 0.000 claims description 28
- 239000002636 mycotoxin Substances 0.000 claims description 28
- 238000002604 ultrasonography Methods 0.000 claims description 28
- 235000008434 ginseng Nutrition 0.000 claims description 24
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 22
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 238000006243 chemical reaction Methods 0.000 claims description 15
- 238000001816 cooling Methods 0.000 claims description 15
- 230000012010 growth Effects 0.000 claims description 15
- 238000002156 mixing Methods 0.000 claims description 15
- 238000007598 dipping method Methods 0.000 claims description 14
- 238000005516 engineering process Methods 0.000 claims description 14
- 238000000605 extraction Methods 0.000 claims description 14
- 238000011081 inoculation Methods 0.000 claims description 14
- 238000009413 insulation Methods 0.000 claims description 14
- 238000012545 processing Methods 0.000 claims description 13
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 claims description 12
- 238000004140 cleaning Methods 0.000 claims description 12
- 238000000227 grinding Methods 0.000 claims description 12
- 238000000926 separation method Methods 0.000 claims description 12
- 239000012141 concentrate Substances 0.000 claims description 11
- 230000008595 infiltration Effects 0.000 claims description 11
- 238000001764 infiltration Methods 0.000 claims description 11
- 238000001035 drying Methods 0.000 claims description 9
- 241000894006 Bacteria Species 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 238000013329 compounding Methods 0.000 claims description 4
- 238000005303 weighing Methods 0.000 claims description 3
- 241000208340 Araliaceae Species 0.000 claims 2
- 238000004040 coloring Methods 0.000 claims 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 abstract description 9
- 230000002766 immunoenhancing effect Effects 0.000 abstract 2
- 238000004321 preservation Methods 0.000 abstract 1
- 229940126673 western medicines Drugs 0.000 abstract 1
- 240000004371 Panax ginseng Species 0.000 description 23
- 235000013305 food Nutrition 0.000 description 21
- 239000003814 drug Substances 0.000 description 12
- 230000006872 improvement Effects 0.000 description 10
- CQIUKKVOEOPUDV-IYSWYEEDSA-N antimycin Chemical compound OC1=C(C(O)=O)C(=O)C(C)=C2[C@H](C)[C@@H](C)OC=C21 CQIUKKVOEOPUDV-IYSWYEEDSA-N 0.000 description 7
- CQIUKKVOEOPUDV-UHFFFAOYSA-N citrinine Natural products OC1=C(C(O)=O)C(=O)C(C)=C2C(C)C(C)OC=C21 CQIUKKVOEOPUDV-UHFFFAOYSA-N 0.000 description 7
- 230000002708 enhancing effect Effects 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 206010047700 Vomiting Diseases 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 235000013402 health food Nutrition 0.000 description 6
- 230000000968 intestinal effect Effects 0.000 description 6
- 238000010025 steaming Methods 0.000 description 6
- 230000006907 apoptotic process Effects 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 4
- 206010060862 Prostate cancer Diseases 0.000 description 4
- 208000005718 Stomach Neoplasms Diseases 0.000 description 4
- 230000001093 anti-cancer Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 206010017758 gastric cancer Diseases 0.000 description 4
- 230000001900 immune effect Effects 0.000 description 4
- 230000003053 immunization Effects 0.000 description 4
- 238000002649 immunization Methods 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 201000011549 stomach cancer Diseases 0.000 description 4
- 206010009944 Colon cancer Diseases 0.000 description 3
- 235000002789 Panax ginseng Nutrition 0.000 description 3
- 208000029742 colonic neoplasm Diseases 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000000378 dietary effect Effects 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 201000001514 prostate carcinoma Diseases 0.000 description 3
- 229940026314 red yeast rice Drugs 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 241000186016 Bifidobacterium bifidum Species 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 2
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 206010008342 Cervix carcinoma Diseases 0.000 description 2
- 208000001132 Osteoporosis Diseases 0.000 description 2
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 2
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 201000008275 breast carcinoma Diseases 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 201000010881 cervical cancer Diseases 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 239000000084 colloidal system Substances 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000005265 energy consumption Methods 0.000 description 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
- 238000003306 harvesting Methods 0.000 description 2
- 231100000784 hepatotoxin Toxicity 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 239000002955 immunomodulating agent Substances 0.000 description 2
- 230000002584 immunomodulator Effects 0.000 description 2
- 229940121354 immunomodulator Drugs 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 230000000116 mitigating effect Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000003607 modifier Substances 0.000 description 2
- 230000000877 morphologic effect Effects 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 239000000955 prescription drug Substances 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 206010065553 Bone marrow failure Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000015634 Rectal Neoplasms Diseases 0.000 description 1
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
- 208000009956 adenocarcinoma Diseases 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000008512 biological response Effects 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000001497 healthy food Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 1
- 238000012342 propidium iodide staining Methods 0.000 description 1
- 201000007094 prostatitis Diseases 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 206010038038 rectal cancer Diseases 0.000 description 1
- 201000001275 rectum cancer Diseases 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
病种 | 胃癌 | 肺癌 | 肝癌 | 结肠癌 | 前列腺癌 | 乳腺癌 | 宫颈癌 | 其他 |
例数 | 22 | 16 | 13 | 10 | 25 | 5 | 6 | 3 |
疗效 | 显著有效 | 较为有效 | 一般有效 | 略微有效 | 无效 |
例数 | 50 | 30 | 15 | 5 | 0 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611260368.7A CN106616999A (zh) | 2016-12-30 | 2016-12-30 | 一种多糖红曲复方抗肿瘤癌固体饮料及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611260368.7A CN106616999A (zh) | 2016-12-30 | 2016-12-30 | 一种多糖红曲复方抗肿瘤癌固体饮料及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106616999A true CN106616999A (zh) | 2017-05-10 |
Family
ID=58837481
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611260368.7A Pending CN106616999A (zh) | 2016-12-30 | 2016-12-30 | 一种多糖红曲复方抗肿瘤癌固体饮料及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106616999A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108514062A (zh) * | 2018-03-07 | 2018-09-11 | 佛山市真红生物制品有限公司 | 多糖红曲复方食疗代餐固体饮料及其制备方法 |
CN110074281A (zh) * | 2018-12-29 | 2019-08-02 | 广州申东供应链科技有限公司 | 一种多糖红曲复方鸡饲料及其制备方法 |
CN110973423A (zh) * | 2019-10-17 | 2020-04-10 | 山东本草生物科技有限公司 | 红曲诺丽果饮料及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103638080A (zh) * | 2013-12-12 | 2014-03-19 | 东莞市双红生物转化技术有限公司 | 人参高活性提取物的制备方法、制品及应用 |
CN104522662A (zh) * | 2014-12-25 | 2015-04-22 | 东莞市双红生物转化技术有限公司 | 红曲菌丝体复方降血糖功能食品及其制备方法 |
CN104522514A (zh) * | 2014-12-25 | 2015-04-22 | 东莞市双红生物转化技术有限公司 | 固态发酵罐及利用该固态发酵罐制备红曲米的方法及其制品 |
-
2016
- 2016-12-30 CN CN201611260368.7A patent/CN106616999A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103638080A (zh) * | 2013-12-12 | 2014-03-19 | 东莞市双红生物转化技术有限公司 | 人参高活性提取物的制备方法、制品及应用 |
CN104522662A (zh) * | 2014-12-25 | 2015-04-22 | 东莞市双红生物转化技术有限公司 | 红曲菌丝体复方降血糖功能食品及其制备方法 |
CN104522514A (zh) * | 2014-12-25 | 2015-04-22 | 东莞市双红生物转化技术有限公司 | 固态发酵罐及利用该固态发酵罐制备红曲米的方法及其制品 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108514062A (zh) * | 2018-03-07 | 2018-09-11 | 佛山市真红生物制品有限公司 | 多糖红曲复方食疗代餐固体饮料及其制备方法 |
CN110074281A (zh) * | 2018-12-29 | 2019-08-02 | 广州申东供应链科技有限公司 | 一种多糖红曲复方鸡饲料及其制备方法 |
CN110973423A (zh) * | 2019-10-17 | 2020-04-10 | 山东本草生物科技有限公司 | 红曲诺丽果饮料及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103211974B (zh) | 一种提高免疫能力的药酒及其应用 | |
CN109938332B (zh) | 一种含麦角硫因的猴头菌保健品制剂及其制备方法 | |
CN100998611A (zh) | 一种以中药为基质的灰树花发酵制备工艺 | |
CN102198115A (zh) | 一种中药提取液与益生菌混合的肠溶型微胶囊 | |
CN102600443B (zh) | 一种提高免疫力的组合物、制法及应用 | |
CN106064993A (zh) | 一种猴头菌的培养基、生物转化菌丝体、生物转化菌丝体的提取物及其用途 | |
CN108498635A (zh) | 对癌症病人放化疗后具康复作用的灵芝中草药制剂 | |
CN108991529B (zh) | 一种健脾养元的食品组合物及其制备方法 | |
CN106616999A (zh) | 一种多糖红曲复方抗肿瘤癌固体饮料及其制备方法 | |
CN105961978A (zh) | 一种益生菌发酵型清热祛湿解暑饮品及其制备方法 | |
CN104799286A (zh) | 一种用于提高免疫力的组合物及其制备方法 | |
CN104031156A (zh) | 夏枯草多糖锌螯合物及其制备方法与在抗癌药物中的应用 | |
CN108434338A (zh) | 以抗癌中草药为原料的扶正补虚中药制剂 | |
CN103908489A (zh) | 一种参芪芝药性菌质双向固体发酵方法 | |
CN103520318B (zh) | 一种增强免疫功能的中药组合物及其制备方法 | |
CN106728208A (zh) | 一种人参灵芝多糖三萜制剂及其制备方法 | |
CN1709150A (zh) | 养生膏滋剂及其加工工艺 | |
CN106039138A (zh) | 一种用于水产养殖的乳酸菌中药发酵抗病毒制剂 | |
CN103919934A (zh) | 预防与治疗癌症复方制剂及其制备方法 | |
CN107893035A (zh) | 一种猴头菌的培养基、黄精生物转化菌丝体、黄精生物转化菌丝体的提取物及其用途 | |
CN106511414A (zh) | 一种治疗肿瘤的药物组合物、其制备方法和应用 | |
CN108576792A (zh) | 一种复方壳寡糖调理癌症的膳食及其制备方法 | |
CN105031290A (zh) | 一种复方铁皮石斛胶囊及其制备方法 | |
CN106668841A (zh) | 一种抗肿瘤牦牛骨胶原蛋白肽组合物及其制备方法 | |
CN111729056A (zh) | 抗癌的药物组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20190326 Address after: 528244 First Floor, Block 2 E, Zhongjin Road, Xinlian Village, Lishui Town, Nanhai District, Foshan City, Guangdong Province Applicant after: FOSHAN ZHENHONG BIOLOGICAL PRODUCTS CO.,LTD. Applicant after: Zheng Haozhen Address before: 523460 Xicheng District, Hengli Town, Dongguan City, Guangdong Province Applicant before: GUANGDONG SHUANGHONG BIOLOGICAL PRODUCTS Co.,Ltd. Applicant before: Zheng Haozhen |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20211118 Address after: 528244 First Floor, Block 2 E, Zhongjin Road, Xinlian Village, Lishui Town, Nanhai District, Foshan City, Guangdong Province Applicant after: FOSHAN ZHENHONG BIOLOGICAL PRODUCTS CO.,LTD. Address before: 528244 First Floor, Block 2 E, Zhongjin Road, Xinlian Village, Lishui Town, Nanhai District, Foshan City, Guangdong Province Applicant before: FOSHAN ZHENHONG BIOLOGICAL PRODUCTS CO.,LTD. Applicant before: Zheng Haozhen |
|
TA01 | Transfer of patent application right | ||
CB02 | Change of applicant information |
Address after: 528000 room 701, building 2, Kehui life technology industry center, No. 2 Kefa Road, Lecong Town, Shunde District, Foshan City, Guangdong Province (residence declaration) Applicant after: Guangdong Zhenhong Biotechnology Co.,Ltd. Address before: 528244 First Floor, Block 2 E, Zhongjin Road, Xinlian Village, Lishui Town, Nanhai District, Foshan City, Guangdong Province Applicant before: FOSHAN ZHENHONG BIOLOGICAL PRODUCTS CO.,LTD. |
|
CB02 | Change of applicant information | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170510 |
|
RJ01 | Rejection of invention patent application after publication |